Avidity Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RNA for the last quarter is 3.54 M USD, and it's 61.56% higher compared to the previous quarter. The net income of Q1 24 is -68.86 M USD.